MYVI
LIVE

Serial Number

97558337

Owner

H. Lundbeck A/S

Attorney

Maren C. Perry

Filing Date

Aug 22, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MYVI Trademark

Serial Number: 97558337 • Registration: 7484469

MYVI is a trademark filed by H. Lundbeck A/S on August 22, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

August 22, 2022

Registration Date

August 27, 2024

Published for Opposition

March 12, 2024

Goods & Services

Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, headaches, migraines, pain, immune and inflammatory disorders and diseases; Diagnostic preparations, substances, reagents and agents for medical purposes

Providing personal support services for patients receiving treatment of medical disorders in the nature of companionship, help with medical forms, emotional counseling, and emotional support

Medical services; clinical services, namely, clinical medical consultation services; therapeutic services, namely, mental health therapy services; healthcare; providing medical and healthcare information; providing medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; providing information about mental health therapy; medical services in the fields of psychiatry, psychology, neurology, and central nervous system diseases and disorders; medical and pharmaceutical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and neurology disorders, diseases and pharmaceuticals; providing medical and medicinal information in the field of diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment, and prevention; providing medical information on-line to patients and clients regarding medical dosages, diagnoses, therapeutic issues and selfmanagement of medical issues; providing medical information to medical professionals and patients relating to the prevention, management, and treatment of headaches, migraines, pain, immune and inflammatory disorders, and neurological disorders and diseases via a website

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 27, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 27, 2024 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 21, 2024 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 10, 2024 ETOF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 22, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 22, 2024 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2024 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 5, 2024 CHAN
ASSIGNED TO LIE
Feb 1, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2023 TROA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 11, 2023 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 11, 2023 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Sep 11, 2023 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 11, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 11, 2023 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 13, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 13, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 13, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 8, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2022 NWOS
NEW APPLICATION ENTERED
Aug 25, 2022 NWAP